Visterra, Inc. clinical trials
Acquired by Otsuka Holdings Co., Ltd., Aug 31, 2018 · source ↗
The registry lists 4 studies whose lead sponsor is Visterra, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 28, 2022.
Before and after it joined Otsuka Holdings Co., Ltd.
- First submitted before Visterra, Inc. became part of Otsuka Holdings Co., Ltd.
- 4
- First submitted after Visterra, Inc. became part of Otsuka Holdings Co., Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Visterra, Inc.4 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Otsuka Holdings Co., Ltd. studies →
- Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza ACompletedNCT03040141Phase 2
Sponsor listed in the registry: Visterra, Inc. · First submitted before Visterra, Inc. became part of Otsuka Holdings Co., Ltd.
- Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza ACompletedNCT02989194Phase 2
Sponsor listed in the registry: Visterra, Inc. · First submitted before Visterra, Inc. became part of Otsuka Holdings Co., Ltd.
- Influenza Challenge Study of VIS410 in Healthy VolunteersCompletedNCT02468115Phase 2
Sponsor listed in the registry: Visterra, Inc. · First submitted before Visterra, Inc. became part of Otsuka Holdings Co., Ltd.
- A Study of VIS410 to Assess Safety and PharmacokineticsCompletedNCT02045472Phase 1
Sponsor listed in the registry: Visterra, Inc. · First submitted before Visterra, Inc. became part of Otsuka Holdings Co., Ltd.